Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | DVA DaVita | ABT Abbott Laboratories |
|---|---|---|
| Price | $190.90 +0.8% | $102.03 -1.0% |
| StockIQ Score | 56C Moderate Risk: Medium | 48D+ Moderate Risk: Medium |
| Technical | 61C+ | 23F |
| Fundamental | 46D+ | 72B |
| Growth | 34F | 45D+ |
| Fair Value | 62C+ | 38F |
| News | 86A | 68B- |
| Quality | 58C | 63C+ |
| Risk | 50C- | 54C- |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
DaVita (DVA) scores higher than Abbott (ABT) on the investor (56 vs 48), technical (61 vs 23) and valuation (62 vs 38) metrics, indicating relatively stronger market and pricing signals. Abbott leads on fundamental (72 vs 46) and growth (45 vs 34) scores, suggesting better underlying financial health and expansion potential.